NXTC: NextCure, Inc. Stock

by  •  • Comments Off on NXTC: NextCure, Inc. Stock

SIC 2834 – Pharmaceutical Preparations

Valuation
Market Cap ($M) 10.78
Enterprise Value ($M) -11.04
Book Value ($M) 55.85
Book Value / Share 1.99
Price / Book 0.19
NCAV ($M) 47.62
NCAV / Share 1.70
Price / NCAV 0.23

Profitability (mra)
Return on Invested Capital (ROIC) -0.80
Return on Assets (ROA) -0.43
Return on Equity (ROE) -0.50

Liquidity (mrq)
Quick Ratio 10.26
Current Ratio 10.26

Balance Sheet (mrq) ($M)
Current Assets 58.90
Assets 67.14
Liabilities 11.28
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 0.00
Operating Income -57.21
Net Income -55.65
Earnings Per Share Basic And Diluted n/a

Cash Flow Statement (mra) ($M)
Cash From Operations -40.80
Cash from Investing 55.31
Cash from Financing 0.14

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)		 Change
(%)
02-14 13G/A Logos Global Management LP 0.00 -100.00
11-13 13G/A Affinity Asset Advisors, LLC 8.22 37.65

Top 13F Investors Shares
(1000)		 Change
(%)		 Value
($1000)		 Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2025-05-01 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q
2025-03-06 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K
2024-11-07 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q
2024-08-01 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2025-05-08 21,595 53,013 40.74
2025-05-07 3,303 83,009 3.98
2025-05-06 23,584 172,411 13.68
2025-05-05 10,399 41,183 25.25

(click for more detail)

Similar Companies
NMRA – Neumora Therapeutics, Inc. NUVL – Nuvalent, Inc.
NVAX – Novavax, Inc. OGI – Organigram Global Inc.
OLMA – Olema Pharmaceuticals, Inc.


Financial data and stock pages provided by
Fintel.io